Some neuropeptides and neurotransmitters are implicated in promoting the risk of migraine occurrence in GERD, including calcitonin gene-related peptide (CGRP), vasoactive intestinal peptide (VIP), and serotonin. This evidence concerns the gene VIP and gastroesophageal reflux disease.